{{ (moduleVm.actions && moduleVm.changeStatus) ? moduleVm.status : '' }} Direct Oral Anticoagulant Reversal in the Pediatric Emergency Department

Activity Steps


Method of Participation in the Learning Process/Evaluation Method

Successful completion of this activity includes reading the entire article and successfully completing the post-quiz and an evaluation form.

Getting the Most out of the Activity

As you prepare to participate in this activity, please reflect on your practice and your patients and identify clinical challenges you hope to have addressed.

While participating in the training, identify ways you can use newly acquired knowledge, strategies, and skills to enhance patient outcomes and your own professional development.

Learning Objectives

After completing this continuing education activity you will be able to:

  1. Describe the pharmacokinetics of direct oral anticoagulants and their reversal agents.
  2. Identify agents available for reversal of anticoagulant agents, dosing and limitations.
  3. Explain when to use targeted reversal agents for direct oral anticoagulants in addition to standard supportive care in the emergency department.
Price: FREE


  • ACCME 1.0 CME

Lippincott Continuing Medical Education Institute, Inc. is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

Lippincott Continuing Medical Education Institute, Inc. designates this enduring material for a maximum of 1.0 AMA PRA Category 1 CreditsTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Professions: Physician
Test Code: PEC1122
Published: November 2022
Expires: 10/31/2024
Required Passing Score: 4/5 (80%)
Authors: Jessica Otero, PharmD, Suzan S. Mazor, MD, and James Leoni, MD